首页> 外文期刊>Journal of microbiology and biotechnology >Thiazinogeldanamycin, a new geldanamycin derivative produced by Streptomyces hygroscopicus 17997
【24h】

Thiazinogeldanamycin, a new geldanamycin derivative produced by Streptomyces hygroscopicus 17997

机译:Thiazinogeldanamycin,一种由吸水链霉菌17997生产的新的格尔德霉素衍生物

获取原文
获取原文并翻译 | 示例
           

摘要

A new geldanamycin (GDM) derivative was discovered and isolated from the fermentation broth of Streptomyces hygroscopicus 17997. Its chemical structure was elucidated as thiazinogeldanamycin by LC-MS, sulfur analysis, and NMR. The addition of cysteine to the fermentation medium significantly stimulated the production level of thiazinogeldanamycin, suggesting cysteine as a precursor of thiazinogeldanamycin production. Although showing a decreased cytotoxicity against HepG2 cancer cells, thiazinogeldanamycin exhibited an improved water solubility and photostability. Thiazinogeldanamycin may represent the first natural GDM derivative characterized so far that uses GDM as its precursor. Its appearance also clearly indicates that an appropriate end-point of fermentation is of critical importance for the maximal production of GDM by Streptomyces hygroscopicus 17997.
机译:从吸水链霉菌17997的发酵液中发现了一种新的格尔德霉素(GDM)衍生物,并通过LC-MS,硫分析和NMR将其化学结构阐明为噻嗪基格尔德霉素。向发酵培养基中添加半胱氨酸显着刺激了噻嗪基格尔德霉素的生产水平,表明半胱氨酸是噻嗪基格尔德霉素生产的前体。尽管显示出降低的对HepG2癌细胞的细胞毒性,但噻嗪凝胶素显示出改善的水溶性和光稳定性。噻嗪基格尔德霉素可以代表迄今为止使用GDM作为其前体的第一个天然GDM衍生物。它的出现也清楚地表明,合适的发酵终点对于吸水链霉菌17997最大程度地生产GDM至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号